Transdermal versus oral estrogen therapy in postmenopausal smokers: Hemodynamic and endothelial effects

被引:26
作者
Girdler, SS
Hinderliter, AL
Wells, EC
Sherwood, A
Grewen, KM
Light, KC
机构
[1] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Cardiol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA
[4] Duke Univ, Ctr Med, Dept Psychiat, Durham, NC USA
关键词
D O I
10.1097/01.AOG.0000103998.48122.0b
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To test the hypothesis that, in postmenopausal smokers, transdermal estrogen would be more effective than oral estrogen in reducing blood pressure (BP) and vascular and norepinephrine responses to stress and in increasing endothelial function and vascular beta(2)-adrenoceptor responsivity. METHODS: By using a randomized, double-blind, placebo controlled design, 82 healthy postmenopausal smokers were tested before and after 6 months of therapy with transdermal estrogen (0.05 mg/d) plus a progestin (2.5 mg/d; n = 31), oral conjugated equine estrogen (0.625 mg/d) plus a progestin (2.5 mg/d; n = 30), or placebo (n = 21). Dependent measures included resting and stress-induced increases in BP, total peripheral resistance, and plasma norepinephrine, as well as endothelial function and beta-adrenoceptor responsivity. RESULTS: When compared with placebo, the transdermal estrogen group showed more consistent reductions in total peripheral resistance at rest and in response to mental stress than the oral estrogen group. Only the transdermal group showed treatment-related reductions in behavioral stress norepinephrine, baseline rest, and behavioral stress BP levels, and increases in vascular beta(2)-adrenoceptor responsivity and endothelium-dependent vasodilation. Posttreatment concentrations of serum estradiol and estrone were lower and the serum estradiol/estrone ratio closer to premenopausal values in the group receiving transdermal estrogen compared with oral estrogen. CONCLUSION: Six months of transdermal estrogen therapy is associated with greater reductions in measures reflecting vascular sympathetic tone than oral estrogen therapy in healthy postmenopausal smokers. Thus, transdermal estrogen may be associated with a more favorable risk/ benefit ratio in postmenopausal smokers, a group at high risk of osteoporosis and cardiovascular disease. (C) 2004 by Ile American College of Obstetricians and Gynecologists.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 49 条
[11]   Estrogen replacement increases beta-adrenoceptor-mediated relaxation of rat mesenteric arteries [J].
Ferrer, M ;
Meyer, M ;
Osol, G .
JOURNAL OF VASCULAR RESEARCH, 1996, 33 (02) :124-131
[12]  
FREY MJ, 1987, J CARDIOVASC PHARM, V10, P545
[13]   Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking [J].
Geisler, J ;
Omsjo, IH ;
Helle, SI ;
Ekse, D ;
Silsand, T ;
Lonning, PE .
JOURNAL OF ENDOCRINOLOGY, 1999, 162 (02) :265-270
[14]   The ability of active versus passive coping tasks to predict future blood pressure levels in normotensive men and women [J].
Girdler, SS ;
Hinderliter, AL ;
Brownley, KA ;
Turner, JR ;
Sherwood, A ;
Light, KC .
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 1996, 3 (03) :233-250
[15]   Smoking status and nicotine administration differentially modify hemodynamic stress reactivity in men and women [J].
Girdler, SS ;
Jamner, LD ;
Jarvik, M ;
Soles, JR ;
Shapiro, D .
PSYCHOSOMATIC MEDICINE, 1997, 59 (03) :294-306
[16]   Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement [J].
Girdler, SS ;
Hinderliter, AL ;
West, SG ;
Grewen, K ;
Steege, J ;
Light, KC .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (05) :590-+
[17]   Physiological action of progesterone in target tissues [J].
Graham, JD ;
Clarke, CL .
ENDOCRINE REVIEWS, 1997, 18 (04) :502-519
[18]   CIGARETTE-SMOKING AND THE ADRENERGIC NERVOUS-SYSTEM [J].
GRASSI, G ;
SERAVALLE, G ;
CALHOUN, DA ;
BOLLA, G ;
MANCIA, G .
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1992, 14 (1-2) :251-260
[19]   BETA-ADRENOCEPTORS IN HUMAN ALVEOLAR MACROPHAGES ISOLATED BY ELUTRIATION [J].
HJEMDAHL, P ;
LARSSON, K ;
JOHANSSON, MC ;
ZETTERLUND, A ;
EKLUND, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (05) :673-682
[20]  
Jacobson BH, 1995, WOMEN HEALTH, V23, P27, DOI 10.1300/J013v23n04_03